Anesthesiologist Assistant in West Palm Beach, FL Accepting Medicare

8 Anesthesiologist Assistant nurses found. Showing 1 - 8

Michael A. Imon, AA-C Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 2201 45th Street, West Palm Beach, FL 33407 Phone: 954-838-2371    Fax: 954-851-1758

Alexandra Bain, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 901 45th St, West Palm Beach, FL 33407 Phone: 561-623-2064

Megan Grace Busman, PA-A Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1309 N Flagler Dr, West Palm Beach, FL 33401 Phone: 561-655-5511

Mrs. Danielle Rose Biancardi, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1309 N Flagler Dr, West Palm Beach, FL 33401 Phone: 786-492-2382

Courtney Fetto, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1309 N Flagler Dr, West Palm Beach, FL 33401 Phone: 561-655-5511

Andre Eduardo Boz, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 901 45th St, West Palm Beach, FL 33407 Phone: 305-693-6100

Erik C Nelson, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2201 45th St, West Palm Beach, FL 33407 Phone: 561-863-3970    Fax: 954-514-3960

Legrand Marseille, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1309 N Flagler Dr, West Palm Beach, FL 33401 Phone: 561-655-5511

News Archive

Takeda, Amylin discontinue pramlintide/metreleptin development program for obesity

Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited today announced that they are discontinuing development of pramlintide/metreleptin, an investigational combination therapy for the treatment of obesity that comprises pramlintide, an analog of the natural hormone amylin, and metreleptin, an analog of the natural hormone leptin.

BUSM, COE receive NIH training grant to examine inflammatory disorders

The National Institutes of Health (NIH) has awarded Boston University School of Medicine (BUSM) and the College of Engineering (COE) a five year, $316,875 training grant to examine inflammatory disorders.

Quark initiates dosing NAION patients in QPI-1007 Phase I study for ocular neuroprotection

Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the discovery and development of RNAi-based therapeutics, today announced it has dosed the first patient with recent onset of non-arteritic anterior ischemic optic neuropathy (NAION) in its ongoing Phase I study of QPI-1007, the Company's proprietary synthetic siRNA drug candidate for ocular neuroprotection.

Abortion issue gets spotlight in swing states

Meanwhile, as the GOP prepares to include tough anti-abortion positions in its party platform, the Associated Press notes that voters in the presidential race will get a stark choice on social issues, including access to birth control and abortion rights.

Bad bedside manna: Bank loans signed in the hospital leave patients vulnerable

Laura Cameron, then three months pregnant, tripped and fell in a parking lot and landed in the emergency room last May — her blood pressure was low and she was scared and in pain. She was flat on her back and plugged into a saline drip when a hospital employee approached her gurney to discuss how she would pay her hospital bill.

Read more Medical News

› Verified 5 days ago